Table 5.
Study and year | Time of fasting before FDG administration (h) | FDG dose (MBq) | Time interval between FDG administration and data acquisition (min) | No. of CT detector rows | Reconstructed slice width (mm) | Intravenous CT contrast | Oral CT contrast | Area of body scanned |
---|---|---|---|---|---|---|---|---|
Fencl et al. [12], 2007 | ≥6 | 350–450 | 60–90 | 2 | 4.0 | Yes and no | Yes | From the skull base to below the groin |
Nassenstein et al. [13], 2007 | ≥4 | 350 | 60 | 2 | -3.0 (head and neck) | Yes | Yes | From the head to the upper thigh |
-5.0 (chest and abdomen) | ||||||||
Fleming et al. [14], 2007 | NR | 555 | 75 | 16 | NR | NR | NR | From the top of the head to midthigh |
Bruna et al. [15], 2007 | ≥6 | 5.5/kg (max. 550) | 60 | NR | NR | NR | NR | From the top of the head to midthigh |
Wartski et al. [16], 2007 | ≥6 | 4–5/kg | 60 | NR | 5.0 | No | No | From the skull to the midthigh |
Ambrosini et al. [18], 2006 | 6 | 370 | 60–90 | NR | NR | NR | NR | “Whole-body” |
Fakhry et al. [20] 2006 | ≥6 | 260–330 | 60 | NR | NR | NR | NR | From the skull base to the thighs |
Pelosi et al. [22], 2006 | ≥6 | 222–370 | 60 | NR | NR | NR | NR | From neck to pelvis or from skull to feet |
Nanni et al. [26], 2005 | ≥6 | 370 | 60–90 | NR | NR | NR | NR | “Total body scan” |
Freudenberg et al. [27], 2005 | ≥10 | 360 | 60 | 2 | -3.0 (head and neck) | -No (head and neck | -No (head and neck) | Head, neck, thorax, abdomen and pelvis |
-5.0 (from thorax to pelvis) | -Yes (thorax to pelvis) | -Yes (thorax to pelvis) | ||||||
Gutzeit et al. [29], 2005 | ≥4 | 350 | 60 | 2 | 5.0 | Yes | Yes | Head, neck, thorax, abdomen and pelvis |
CT: computed tomography
FDG: 18F-fluoro-2-deoxyglucose
NR: not reported